How to Help Your Patients Find Auvelity XR in Stock: A Provider's Guide

How to Help Your Patients Find Auvelity XR in Stock: A Provider's Guide

Your patients are coming to you frustrated. They have a prescription for Auvelity XR (dextromethorphan/bupropion extended-release), but their pharmacy says they don't carry it or can't get it. As a prescriber, you can play a pivotal role in helping them navigate this challenge. This guide offers actionable steps to streamline the process.

The Current State of Auvelity XR Availability in 2026

Auvelity XR is not on the FDA drug shortage list as of early 2026. Axsome Therapeutics continues to manufacture and distribute the medication. The availability challenges are primarily at the pharmacy level — a function of stocking decisions, wholesaler allocation, and the economics of carrying a high-cost brand-name medication.

This is an important distinction to communicate to patients: their medication exists in the supply chain. It's a matter of finding the right pharmacy.

Why Your Patients Still Can't Find Auvelity XR

Wholesaler Allocation Limits

The three major wholesalers (McKesson, Cardinal Health, AmerisourceBergen) use allocation systems that may limit order quantities for pharmacies without established purchasing history for a given drug. A pharmacy trying to order Auvelity XR for the first time may face delays or quantity limits.

Demand Concentration

Prescribing of Auvelity XR is concentrated among psychiatrists and providers treating patients with difficult-to-manage depression. This creates geographic pockets of high demand — particularly in metropolitan areas with dense psychiatry practices — while pharmacies in other areas may never receive a prescription and therefore never stock it.

Pharmacy Economics

With a wholesale cost approaching $900-$1,300 per month of therapy, Auvelity XR represents a significant inventory investment for pharmacies. Many pharmacy managers are reluctant to stock a medication that may sit on the shelf, particularly if reimbursement is uncertain or if prior authorization delays mean prescriptions go unfilled.

Brand-Only Status

The absence of a generic alternative means pharmacies cannot stock a lower-cost equivalent. This limits options for both the pharmacy and the patient, and makes the manufacturer copay card program especially important for maintaining access.

What You Can Do to Help Your Patients

1. Use the Medfinder Provider Portal

The Medfinder provider portal allows your staff to search for pharmacies with Auvelity XR in stock on behalf of patients. This is often faster and more efficient than having patients call multiple pharmacies themselves. Consider integrating this into your prescribing workflow for any patient starting Auvelity XR.

2. Advise Patients to Plan Ahead

Coach patients to contact their pharmacy at least 7-10 days before their refill is due. This gives the pharmacy time to order Auvelity XR from their wholesaler if it's not in stock. Waiting until the last minute often results in treatment gaps.

3. Recommend Trying Independent Pharmacies

Independent pharmacies often have more flexibility in their ordering and stocking decisions than chain pharmacies. They may work with different wholesalers and are typically more willing to special-order medications for their patients. Maintaining a list of reliable independent pharmacies that stock Auvelity XR can be a valuable practice resource.

4. Prescribe With Flexibility in Mind

When clinically appropriate, discuss with patients the possibility of dose flexibility. The standard 45 mg/105 mg strength is the most widely stocked. If a pharmacy has the medication in stock at the appropriate strength, having the prescription ready to send immediately can prevent the stock from being allocated to another patient.

5. Ensure Patients Know About Savings Programs

Cost barriers are closely linked to access barriers. Patients who can't afford their copay may abandon prescriptions even when the pharmacy has stock. Make sure every Auvelity XR patient is aware of:

• Auvelity Savings Card: Reduces copay to as little as $10/fill for commercially insured patients — auvelity.com/savings
• Axsome Patient Assistance Program: Provides medication at no cost for qualifying uninsured/underinsured patients
• NeedyMeds and RxAssist for additional assistance resources

Alternative Options to Discuss With Patients

If a patient cannot access Auvelity XR despite best efforts, the following alternatives may warrant discussion:

• Bupropion (Wellbutrin XL/SR): Provides one mechanistic component of Auvelity XR. Widely available generic, $10-$30/month. Does not offer NMDA receptor antagonism.
• Esketamine (Spravato): NMDA receptor antagonist nasal spray for treatment-resistant depression. Requires REMS certification and in-office administration. Strong efficacy data for TRD.
• Vortioxetine (Trintellix): Multimodal antidepressant, may be particularly beneficial for patients with cognitive symptoms of depression. Brand-only, similar cost challenges.

Document any alternative trials thoroughly — this strengthens future PA appeals should the patient return to Auvelity XR.

Streamlining Your Practice Workflow

Given the recurring nature of access challenges with newer brand medications, consider implementing these workflow optimizations:

Designate a Point Person for Medication Access

Assign a medical assistant or patient navigator to handle medication access issues — including prior authorizations, savings card enrollment, and pharmacy stock verification. This reduces prescriber burden and improves patient satisfaction.

Build Availability Checks Into Your Prescribing Process

Before sending a new Auvelity XR prescription, use the Medfinder provider portal or call a known pharmacy to confirm stock. This prevents the frustrating cycle of prescription → denial → callback.

Keep a Pharmacy Resource List

Maintain a running list of pharmacies that reliably stock Auvelity XR, including both local options and mail-order pharmacies. Update this list periodically as stocking patterns change.

Proactive PA Submission

For patients you anticipate starting on Auvelity XR, submit the prior authorization proactively — before the first prescription, if possible. Include complete documentation of prior antidepressant trials, clinical rationale, and supporting literature.

Final Thoughts

Helping patients access Auvelity XR requires a proactive, team-based approach. The medication is available — the challenge is connecting patients with pharmacies that stock it and ensuring cost isn't a barrier to adherence.

Key actions:

1. Use the Medfinder provider portal to locate pharmacies with Auvelity XR in stock
2. Enroll every patient in the Auvelity Savings Card program
3. Build medication access support into your practice workflow
4. Maintain a list of reliable pharmacies and update it regularly

Related provider resources:

• Auvelity XR Shortage: What Providers Need to Know in 2026
• How to Help Patients Save Money on Auvelity XR

Share with your patients: Auvelity XR Shortage Update for Patients